Style | Citing Format |
---|---|
MLA | Alipour F, et al.. "Prevalence of Cataracts in Iran Based on the Persian Eye Cohort Study." Scientific Reports, vol. 14, no. 1, 2024, pp. -. |
APA | Alipour F, Abdi P, Asadigandomani H, Rezakhani M, Moosaie F, Jafari F, Yaseri M, Motamedgorji N, Khalili F, Tavakoli R, Tahkor A, Mohseni M, Salimpour S, Aref SMJM, Mirzaei M, Soleimani M, Shahraki K, Alizade Y, Shoja MR, ... Hashemi H (2024). Prevalence of Cataracts in Iran Based on the Persian Eye Cohort Study. Scientific Reports, 14(1), -. |
Chicago | Alipour F, Abdi P, Asadigandomani H, Rezakhani M, Moosaie F, Jafari F, Yaseri M, et al.. "Prevalence of Cataracts in Iran Based on the Persian Eye Cohort Study." Scientific Reports 14, no. 1 (2024): -. |
Harvard | Alipour F et al. (2024) 'Prevalence of Cataracts in Iran Based on the Persian Eye Cohort Study', Scientific Reports, 14(1), pp. -. |
Vancouver | Alipour F, Abdi P, Asadigandomani H, Rezakhani M, Moosaie F, Jafari F, et al.. Prevalence of Cataracts in Iran Based on the Persian Eye Cohort Study. Scientific Reports. 2024;14(1):-. |
BibTex | @article{ author = {Alipour F and Abdi P and Asadigandomani H and Rezakhani M and Moosaie F and Jafari F and Yaseri M and Motamedgorji N and Khalili F and Tavakoli R and Tahkor A and Mohseni M and Salimpour S and Aref SMJM and Mirzaei M and Soleimani M and Shahraki K and Alizade Y and Shoja MR and Khataminia GR and Behrouz MJ and Hashemi H}, title = {Prevalence of Cataracts in Iran Based on the Persian Eye Cohort Study}, journal = {Scientific Reports}, volume = {14}, number = {1}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Alipour F AU - Abdi P AU - Asadigandomani H AU - Rezakhani M AU - Moosaie F AU - Jafari F AU - Yaseri M AU - Motamedgorji N AU - Khalili F AU - Tavakoli R AU - Tahkor A AU - Mohseni M AU - Salimpour S AU - Aref SMJM AU - Mirzaei M AU - Soleimani M AU - Shahraki K AU - Alizade Y AU - Shoja MR AU - Khataminia GR AU - Behrouz MJ AU - Hashemi H TI - Prevalence of Cataracts in Iran Based on the Persian Eye Cohort Study JO - Scientific Reports VL - 14 IS - 1 SP - EP - PY - 2024 ER - |